However, it should be noted that experimentsutilising anti-IL-1 treatments have not yet been tested in humans and when given alone, anti-IL-1 treatments do not reduce the burden of existing bone metastasis and can increase growth of soft tissue tumours. The gene discussed is IL1A; the disease is soft tissue neoplasm.